Who makes Drug: ABBV-1088?

Drug: ABBV-1088 is developed by AbbVie.

Last reviewed 2026-05-14 · How we verify

Drug: ABBV-1088

AbbVie · Phase 1 active Small molecule

At a glance

Generic name	Drug: ABBV-1088
Sponsor	AbbVie
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Drug: ABBV-1088 CI brief — competitive landscape report
Drug: ABBV-1088 updates RSS · CI watch RSS
AbbVie portfolio CI